Skip to main content

Table 6 Public Spending on 3 Orphan Medicinal Products with Reimbursement in 5 EU Countries in 2013–14

From: The European challenges of funding orphan medicinal products

 

Average spending per 100,000 inhabitants in 2013–14

Ratio of spending compared to the average of 5 countries

Belgium

94,744 €

1,39

Bulgaria

33,387 €

0,49

Czech Republic

80,526 €

1,18

Poland

51,565 €

0,76

Slovenia

80,699 €

1,18